LeaderPortfolio
Milken
Michael Milken
Rank #517
UNITED STATESfinance-investmentsInvestments

Michael Milken

Net Worth
$7.472B
0% (24h)
Michael Milken is an American financier and philanthropist, best known for his pioneering role in the high-yield bond market, earning him the moniker "Junk Bond King." Born in 1946, Milken graduated from the University of California, Berkeley, and earned an MBA from the Wharton School. His career at Drexel Burnham Lambert saw him revolutionize corporate finance, funding thousands of companies and creating millions of jobs. Despite facing legal challenges and serving time in prison for securities fraud, Milken's net worth is currently estimated at $7.5 billion, and he remains a significant figure in both finance and philanthropy, dedicating substantial resources to medical research and education.

How to read Michael Milken's profile

Public net-worth figures are estimates. They combine observable inputs—typically listed equity, disclosed transactions, and market prices—with editorial judgment where filings are incomplete (for example, private holdings, debt, or cross-holdings). For Michael Milken, we anchor the narrative to Silver Rock Financial and Investments, then update the headline number as markets move. The chart on this page is meant to show trajectory, not a certified balance sheet.

When you see $7.472B alongside global rank #517, interpret it as our best synthesis of widely cited ownership and price signals—not a claim about cash on hand. Estimates can diverge from other publishers because of different treatment of options, trusts, charitable vehicles, or illiquid assets. We document the general approach in methodology and welcome corrections via corrections.

Country (UNITED STATES) and career milestones on this page are curated for reader context; they should be verified against primary sources when used for research. Editorial metadata for this profile is refreshed on a rolling basis, with deeper audits at least annually (last noted cycle: 2026).

Looking for depth? When available, the dossier and timeline sections below add long-form context beyond the headline number—prioritize those modules when evaluating claims about strategy, controversies, or philanthropic commitments.

The Full Dossier

Early Life and Education

Michael Robert Milken was born on July 4, 1946, in Encino, California, to a middle-class Jewish family. He attended Birmingham High School, where he excelled as a student and was involved in various extracurricular activities. Milken graduated from the University of California, Berkeley, with highest honors in 1968, and went on to earn his MBA from the Wharton School of the University of Pennsylvania.

Rise to Success

Milken's career took off in 1969 when he began working at Drexel Harriman Ripley, which later became Drexel Burnham Lambert. He is credited with developing the high-yield bond market, which provided capital to smaller companies and fueled the leveraged buyout boom of the 1980s. Milken's innovative approach to finance transformed the landscape of corporate America, funding over 3,200 companies and creating millions of jobs. He became known as the "Junk Bond King" for his work in this area. By 1976, his income at Drexel Burnham Lambert was estimated at $5 million a year.

Key Business Strategies

Milken's key business strategy revolved around identifying and investing in high-yield bonds, which offered higher returns than traditional bonds but carried greater risk. He focused on assessing the potential of companies rather than solely relying on their credit ratings. This approach allowed him to provide capital to a wide range of businesses, fostering innovation and growth. He also emphasized research and understanding of financial history and credit, which he believed was the key to success in the financial markets.

Philanthropy

After facing legal issues in the late 1980s, Milken shifted his focus to philanthropy. He has founded and supported numerous initiatives in medical research, education, and public health. Notably, he founded the Prostate Cancer Foundation in 1993 after his own battle with prostate cancer. He also co-founded the Milken Family Foundation, which supports education and youth programs, and FasterCures, an organization dedicated to accelerating progress against life-threatening diseases. Milken has donated significantly to the Center for Advancing the American Dream in Washington D.C., which promotes equal access to education and healthcare.

Career Timeline

2020

Pardoned by President Trump

Received a Presidential pardon.

1993

Founded Prostate Cancer Foundation

Shifted focus to philanthropy.

1990

Pled guilty to securities fraud

Faced legal consequences.

1970s-1980s

Developed High-Yield Bond Market

Revolutionized corporate finance.

1973

Drexel merged with Burnham and Company

Became head of convertibles at Drexel Burnham Lambert.

1971

Head of Drexel Burnham's bond-trading department

Took on a leadership role in bond trading.

1969

Joined Drexel Harriman Ripley

Began his Wall Street career.

Philanthropic Impact

Medical Research$XB

Prostate Cancer Foundation

Founded to fund research on prostate cancer.

Education & Youth Programs$XB

Milken Family Foundation

Supports education and youth programs.

Medical Research$XB

FasterCures

Dedicated to accelerating progress against life-threatening diseases.

Think Tank$XB

Milken Institute

A non-partisan economic think tank.

Social Initiatives$0.5B

Milken Center for Advancing the American Dream

Promotes equal access to education, job training, financing and health care.

Key Business Ventures & Holdings

CompanyStakeValue
On Demand Pharmaceuticals
Immortals
K12 INC

Net Worth History

In-Depth Analysis

Early Life and Education

Michael Robert Milken was born on July 4, 1946, in Encino, California, to a middle-class Jewish family. He attended Birmingham High School, where he excelled as a student and was involved in various extracurricular activities. Milken graduated from the University of California, Berkeley, with highest honors in 1968, and went on to earn his MBA from the Wharton School of the University of Pennsylvania.

Rise to Success

Milken's career took off in 1969 when he began working at Drexel Harriman Ripley, which later became Drexel Burnham Lambert. He is credited with developing the high-yield bond market, which provided capital to smaller companies and fueled the leveraged buyout boom of the 1980s. Milken's innovative approach to finance transformed the landscape of corporate America, funding over 3,200 companies and creating millions of jobs. He became known as the "Junk Bond King" for his work in this area. By 1976, his income at Drexel Burnham Lambert was estimated at $5 million a year.

Key Business Strategies

Milken's key business strategy revolved around identifying and investing in high-yield bonds, which offered higher returns than traditional bonds but carried greater risk. He focused on assessing the potential of companies rather than solely relying on their credit ratings. This approach allowed him to provide capital to a wide range of businesses, fostering innovation and growth. He also emphasized research and understanding of financial history and credit, which he believed was the key to success in the financial markets.

Philanthropy

After facing legal issues in the late 1980s, Milken shifted his focus to philanthropy. He has founded and supported numerous initiatives in medical research, education, and public health. Notably, he founded the Prostate Cancer Foundation in 1993 after his own battle with prostate cancer. He also co-founded the Milken Family Foundation, which supports education and youth programs, and FasterCures, an organization dedicated to accelerating progress against life-threatening diseases. Milken has donated significantly to the Center for Advancing the American Dream in Washington D.C., which promotes equal access to education and healthcare.

Data Sources & Methodology

Figures for Michael Milken are synthesized from the sources below and cross-checked against our net worth methodology. Estimates may lag market moves; see corrections to report discrepancies.